STAT
SEPTEMBER 13, 2024
A close contact of the person in Missouri who had an unexplained H5N1 bird flu infection last month was also sick around the same time, but was not tested for influenza, the Centers for Disease Control and Prevention reported on Friday. The CDC revealed the previously undisclosed information in FluView , its weekly report on influenza activity.
PharmaVoice
SEPTEMBER 13, 2024
Three of the largest fundraising rounds in 2024 show where investors are willing to place their bets in biotech.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
SEPTEMBER 13, 2024
For more cancer coverage, sign up for STAT’s pop-up newsletter focused on this weekend’s European Society for Medical Oncology conference, one of the biggest oncology meetings of the year. Details here. When Rachel Guberman found out she had brain cancer, she did so much reading and Googling about the disease that she joked she had reached the end of the internet.
ALiEM - Pharm Pearls
SEPTEMBER 13, 2024
A 32-year-old male with no significant past medical history presented to the emergency department (ED) from an outside hospital for further management of right eye pain and vision loss sustained after he was struck by a metal wire while at work. The patient presented to an outside “eye doctor” and was told to go to the nearest hospital for evaluation.
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
STAT
SEPTEMBER 13, 2024
BARCELONA, Spain — A targeted immunotherapy being developed by the biotech iTeos Therapeutics and GSK delivered promising response rates in patients with a type of lung cancer, propelling the treatment into a pivotal Phase 3 trial and adding fuel to a broader debate about the validity of the target. The companies reported on Saturday that their combination of a TIGIT-targeting antibody and GSK’s Jemperli increased the percentage of patients who saw their tumors shrink versus those
Pharmacy Is Right For Me
SEPTEMBER 13, 2024
Written by: Toni Mikhael, PharmD, Touro College of Pharmacy Class of 2024. PGY-1 Pharmacy Resident, WellSpan Ephrata Community Hospital, Ephrata, PA Edited by: Anastasiya Shor, PharmD, BCPS Pharmacy school is a challenging but rewarding journey. As students embark on this demanding path, it becomes crucial to equip themselves with a toolkit for success.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
pharmaphorum
SEPTEMBER 13, 2024
It's known that excessive use of earbuds at high volumes can cause hearing loss, so somewhat ironic that the FDA has just authorised software that can turn Apple AirPods into hearing aids.The green light is for Hearing Aid Feature (HAF), an app compatible with Apple's AirPods Pro earbuds that amplifies sounds and can be used for people aged 18 and over with perceived mild to moderate hearing impairment.
STAT
SEPTEMBER 13, 2024
I first met Jane (not her real name, of course) on a Friday afternoon in our clinic. She was referred for further evaluation of her chest pain, which, in the context of her family history of early-onset heart attacks and her morbid obesity, understandably concerned her primary care doctor. In the exam room, we dissected her symptoms and decided we’d investigate them further with a stress test.
pharmaphorum
SEPTEMBER 13, 2024
Eli Lilly has added $1 billion to its investment plan for a new manufacturing facility in Ireland that will be used to produce its Alzheimer's therapy donanemab.The facility at a business park in Raheen, Limerick, was first announced in 2022 and this is the second time that Lilly has opted to double its investment in the site, taking the total above $2 billion and reinforcing the company's close ties to Ireland's pharma manufacturing sector.
STAT
SEPTEMBER 13, 2024
Swiss pharma giant Roche won approval from the Food and Drug Administration on Friday for an injectable version of its blockbuster multiple sclerosis therapy Ocrevus, cutting down the time needed to treat patients and potentially staving off growing competition. The approval was driven by the results of a late-stage trial , OCARINA II, in which the company showed that delivering Ocrevus as a 10-minute injection beneath the skin worked as well as the current approach, an hours-long intravenous in
Speaker: Joe Sharpe and James Carlson
In the world of small business management, the challenge of managing payroll & HR efficiently while scaling operations can be overwhelming. Yet, with the right strategies in place, these challenges can become opportunities for growth and innovation. In this session, Joe Sharpe, Senior Director of Managed Payroll Services at IRIS, will reveal practical methods and expert insights for outsourcing and streamlining payroll processes, resulting in substantial time and resource savings.
The Pharmacist
SEPTEMBER 13, 2024
Community Pharmacy England (CPE) has revealed it plans to ask for more of the £645m set out as an investment in the sector last November to be used to offset wider cost pressures facing the sector. When the highly anticipated Pharmacy First common conditions service was launched in England, it was backed by a £645m […] The post CPE ‘pushing for’ £645m investment to cover wider cost pressures appeared first on The Pharmacist.
STAT
SEPTEMBER 13, 2024
This is the online edition of ESMO in 30 Seconds, a pop-up newsletter from the European Society for Medical Oncology’s annual meeting in Barcelona, Spain. Sign up for the remaining editions here. One of the big presentations of this year’s ESMO (at least in our view) comes tomorrow morning bright and early. David Spigel of Sarah Cannon Research Institute in Nashville will unveil results from the GALAXIES Lung-201 study of an anti-TIGIT therapy from iTeos Therapeutics and GSK in non
Express Pharma
SEPTEMBER 13, 2024
The world massively relies on the developments that continue to take place in the pharmaceutical industry to experience an improved quality of life. From producing drugs for rare forms of cancer to generating highly effective vaccinations for various epidemics and pandemics, this industry has always played a pivotal role in safeguarding public health.
STAT
SEPTEMBER 13, 2024
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning, and congratulations on making it through another week. What’s been helping me get through this week is this baby hippo in Thailand called Moo Deng (which apparently translates to Bouncy Pig). She is very likely the cutest and most relatable animal I’ve ever seen.
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
BioPharma Dive
SEPTEMBER 13, 2024
During an investor presentation Thursday, executives admitted to being overly optimistic their vaccine could wrest significant market share away from GSK's and Pfizer's products this year.
STAT
SEPTEMBER 13, 2024
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.
pharmaphorum
SEPTEMBER 13, 2024
The PM Society Digital Awards 2024, an annual event in the healthcare marketing industry sponsored by Twist Health, held its 15th ceremony at The Brewery in London on 12th September.
STAT
SEPTEMBER 13, 2024
BARCELONA, Spain — Adding a second immunotherapy from Bristol Myers Squibb to an existing checkpoint inhibitor and chemotherapy improved responses for certain patients with a type of lung cancer, steering the approach into a Phase 3 study. The Phase 2 RELATIVITY-104 trial was another hurdle for BMS’ Opdualag, which is essentially a combination of the company’s powerhouse PD-1 inhibitor Opdivo and relatlimab, which targets another checkpoint called LAG-3.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
The Pharmacist
SEPTEMBER 13, 2024
The Darzi review must be followed by a ‘significant shift’ in resources towards community and primary care services, the Independent Association of Pharmacies (IPA) has said in a letter to the government. A delegate of pharmacists representing the IPA took to Downing Street on Thursday to hand in a letter to the prime minister and […] The post IPA takes pharmacy funding demands to No 10 following Darzi review appeared first on The Pharmacist.
STAT
SEPTEMBER 13, 2024
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda has possibilities. We plan to catch up on sundry tasks, promenade with the official mascots and escort Mrs. Pharmalot to an event or two. We also hope to make time for another listening party, where the rotation will likely include this , this , this , this and this.
Express Pharma
SEPTEMBER 13, 2024
Akums Drugs and Pharmaceuticals has been awarded a patent for its room temperature stable oral suspension of Hydroxyurea, designed for managing Sickle Cell Disease (SCD). This formulation aims to overcome the storage and accessibility issues typically associated with Hydroxyurea solutions, which require refrigeration. Sickle Cell Disease, a genetic blood disorder, leads to severe health complications, including anemia and frequent pain episodes.
The Pharmacist
SEPTEMBER 13, 2024
Pregnant women who have limited access to healthy, nutritious and affordable food are up to four times more likely to have poor mental health, including anxiety and depression, new research shows. In the study, researchers found that women who were pregnant and experiencing a lack of access to good quality food, known as ‘food insecurity’, […] The post Food insecurity puts pregnant women at risk of both mental and physical illness appeared first on The Pharmacist.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Express Pharma
SEPTEMBER 13, 2024
Genpact, a global professional services firm, and STADA, a manufacturer of consumer healthcare, generic, and specialty pharma medicines, have announced the renewal of their multi-year partnership. The partnership aims to further streamline, scale, and de-risk STADA’s finance operations, creating competitive advantages. Sanjiv Tandon, Global Business Unit Leader, Life Sciences and Healthcare at Genpact, said, “This renewal exemplifies our leadership in finance and accounting services.
Pharmaceutical Technology
SEPTEMBER 13, 2024
The US Food and Drug Administration (FDA) has approved Roche's Tecentriq Hybreza, a subcutaneous anti-PD-(L)1 cancer immunotherapy.
Express Pharma
SEPTEMBER 13, 2024
Sunsure Energy and Lupin have announced the signing of a 21 MW (31.5 MWp) solar Open Access Power Purchase Agreement (PPA). Under this agreement, Sunsure will provide solar power to Lupin’s Tarapur facility in India, sourced from its 100 MW (150 MWp) solar plant in Solapur. This partnership represents Lupin’s continued focus on increasing the use of renewable energy across its manufacturing plants.
Pharmaceutical Technology
SEPTEMBER 13, 2024
R&D frameworks are in place for the next pandemic-causing pathogen, but ways to derisk development are unclear.
Express Pharma
SEPTEMBER 13, 2024
Sanofi Consumer Healthcare India (SCHIL) has successfully listed its equity shares on BSE and the National Stock Exchange of India (NSE). The listing was celebrated with the ringing of the opening bell at BSE by Himanshu Bakshi, Managing Director of SCHIL. Commenting on the occasion, Himanshu Bakshi said, “India’s consumer healthcare market has vast potential.
Pharmaceutical Technology
SEPTEMBER 13, 2024
Distribution of the self-amplifying mRNA vaccine Kostaive is set to align with a planned October 2024 Covid-19 vaccination campaign.
pharmaphorum
SEPTEMBER 13, 2024
Cellino Biotech has received funding from the US government to develop a scalable biomanufacturing platform for personalised regenerative medicines derived from patients' own stem cells.The $25 million award from the Advanced Research Projects Agency for Health (ARPA-H) will be used to develop Cellino's NEBULA system, which according to the firm's chief technology Matthias Wagner can "effectively print new cells and new tissues for patients using their own DNA.
Pharma Times
SEPTEMBER 13, 2024
Innovative immunotherapy drug HTL0039732 shows potential in trials
pharmaphorum
SEPTEMBER 13, 2024
UK biotech F2G has raised $100 million as it prepares to refile its olorofim candidate for invasive fungal infections, which was turned down last year by the FDA.The Manchester-based company said the new cash will help it to complete the late-stage development of olorofim, a novel oral antifungal for invasive aspergillosis and other serious fungal infections, to support the company during the regulatory review process, and prepare for a commercial launch in the US.
Pharma Times
SEPTEMBER 13, 2024
GlobalData emphasises importance of Improved clinical trials
Expert insights. Personalized for you.
364 
Let's personalize your content